GSK plc
CIK
1131399
Location
London, X0
Portfolio Value
Small
$602,220,433
Diversification
Moderately concentrated
Filing Date
Global Rank
#2,574
/ 8,700
▲ 587
Top Industry
Biotechnology
99.1%
Period ended 3 months ago
Filed Aug 13, 2026 · 33d
3 quarters · since Dec 2025
Portfolio Concentration
13 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Top Position
29.2%
+3.6 pts
Top 5
83.2%
+2.2 pts
Top 10
97.5%
+0.2 pts
HHI
1,680
Moderately concentrated+83
Portfolio Trend
3 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $602,220,433 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedNo qualifying positions this quarter.
Trimmed
Positions the filer reducedNo qualifying positions this quarter.
New Positions
Positions the filer opened this quarterNo qualifying positions this quarter.
Sold Out
Positions the filer fully exitedNo qualifying positions this quarter.
13 tracked positions ·
$602,220,433 total
· filing declares
13 positions · $602,220,442
· as of Jun 30, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| CRSP |
CRISPR Therapeutics AG
Healthcare
|
Held | 3,220,627 | $175,652,996 | 29.17% | |
| WVE |
Wave Life Sciences, Inc.
Healthcare
|
Held | 18,245,691 | $106,007,464 | 17.60% | |
| VIR |
Vir Biotechnology, Inc.
Healthcare
|
Held | 8,550,954 | $87,134,221 | 14.47% | |
| BNTX |
BioNTech SE
Healthcare
|
Held | 889,824 | $82,798,123 | 13.75% | |
| IDYA |
IDEAYA Biosciences, Inc.
Healthcare
|
Held | 1,333,333 | $49,693,320 | 8.25% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
Held | 340,434 | $29,001,572 | 4.82% | |
| LYEL |
Lyell Immunopharma, Inc.
Healthcare
|
Held | 1,512,659 | $21,252,858 | 3.53% | |
| SPRO |
Spero Therapeutics, Inc.
Healthcare
|
Held | 9,190,606 | $20,311,239 | 3.37% | |
| NKTX |
Nkarta, Inc.
Healthcare
|
Held | 3,150,732 | $8,916,571 | 1.48% | |
| FULC |
Fulcrum Therapeutics, Inc.
Healthcare
|
Held | 1,785,714 | $6,535,713 | 1.09% | |
| BCYC |
Bicycle Therapeutics PLC
Healthcare
|
Held | 1,529,561 | $6,485,338 | 1.08% | |
| CVRX |
CVRx, Inc.
Healthcare
|
Held | 1,007,583 | $5,178,976 | 0.86% | |
| RGNX |
REGENXBIO Inc.
Healthcare
|
Held | 271,456 | $3,252,042 | 0.54% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.